GSK3B and Alzheimer disease: It was found that the expression levels of Wnt signaling pathway genes in the medial temporal lobe of AD patients changed, and the hyperphosphorylation of GSK-3β in the pathway co-occurred with tau aggregation in insoluble neurofibrillary tangles in the brain of AD patients [50].